Safety and Efficacy of Overdilation of 10 mm Viatorr Transjugular Intrahepatic Portosystemic Shunt Stents Using 12 mm Balloons

Abstract

Objective The aim of this study was to evaluate overdilation of 10-mm standard and 8–10 mm controlled-expansion Viatorr stents to 12 mm during transjugular intrahepatic portosystemic shunt (TIPS) placement when insufficient reduction (<50%) in portosystemic gradient (PSG) is achieved with standard 10 mm dilation.

Materials and Methods It is a single-institution, institutional review board-approved, retrospective review of TIPS (2013–2022) to identify patients in the overdilation group (12 mm dilation of a 10-mm stent) and a control group (10 mm dilation of a 10-mm stent) matched for age, indication, stent type, Model for End-Stage Liver Disease (MELD) score, pre-TIPS PSG, and variceal embolization. Stent diameter, technical success, clinical outcomes, and adverse events were assessed for both groups.

Results TIPS was created for the overdilation group (n = 35, 57 ± 11 years, 69% male; MELD: 14 ± 5) and control group (n = 35, 57 ± 11 years, 83% male; MELD: 14 ± 5). Overdilation to 12 mm adequately reduced PSG by more than 50% (55 vs. 65% in the control group, p = 0.11). The stent diameter was larger in the overdilation group on cross-sectional imaging (9.8 ± 0.2 vs. 9.5 ± 0.4 mm, p < 0.001), with an estimated 57% higher volume flow rate (p = 0.002). Patients were followed for a median of 11.3 months (range: 0.03–75) and 15.6 months (range: 0.03–106) in the overdilation and control groups, respectively. There was an equivalent rate of ascites resolution (56 vs. 63%, p = 0.68) and rebleeding (13 vs. 17%, p = 0.82) in the overdilation and control groups, with a similar risk of new-onset hepatic encephalopathy (41 vs. 33%, p = 0.51) and TIPS occlusion (11 vs. 9%, p = 0.69). Overdilation did not result in any instance of stent fracture.

Conclusion Overdilation of 10-mm Viatorr stents with 12 mm balloons may provide benefit by potentially reducing PSG further for patients initially having inadequate PSG reduction with short-term safety.

Keywords

portal hypertension - ascites - gastrointestinal bleeding - transjugular intrahepatic portosystemic shunt - stent dilation - hepatic encephalopathy

Institutional Review Board (IRB) Approval

IRB-exempt approval was obtained from the IRB. The requirement for informed consent was waived by the IRB.

Publication History

Article published online:
19 April 2024

• References

• 1 Dariushnia SR, Haskal ZJ, Midia M. et al; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2016; 27 (01) 1-7
• 2 Boike JR, Thornburg BG, Asrani SK. et al; Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension. Clin Gastroenterol Hepatol 2022; 20 (08) 1636-1662.e36
• 3 American College of Radiology. ACR–SIR–SPR Practice Parameter for the Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS). Revised 2022 (Resolution 18); Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/TIPS.pdf. Accessed September 05, 2022
• 4 Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41 (02) 386-400
• 5 Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2001; 96 (12) 3379-3383
• 6 Narahara Y, Kanazawa H, Fukuda T. et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol 2011; 46 (01) 78-85
• 7 Riggio O, Ridola L, Angeloni S. et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 2010; 53 (02) 267-272
• 8 Miraglia R, Maruzzelli L, Tuzzolino F, Petridis I, D'Amico M, Luca A. Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFE-covered stents. Radiology 2017; 284 (01) 281-288
• 9 Wang Q, Lv Y, Bai M. et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol 2017; 67 (03) 508-516
• 10 Praktiknjo M, Abu-Omar J, Chang J. et al. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep Innov Hepatol 2021; 3 (03) 100264
• 11 He FL, Wang L, Yue ZD, Zhao HW, Liu FQ. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. World J Gastroenterol 2014; 20 (33) 11835-11839
• 12 Raissi D, Yu Q, Nisiewicz M, Krohmer S. Parallel transjugular intrahepatic portosystemic shunt with Viatorr^® stents for primary TIPS insufficiency: case series and review of literature. World J Hepatol 2019; 11 (02) 217-225
• 13 Alwarraky MS, Elzohary HA, Melegy MA, Mohamed A. Parallel transjugular intrahepatic portosystemic shunt (TIPS) for TIPS dysfunction: technical and patency outcome. Egypt J Radiol Nucl Med 2020; 51 (01) 229
• 14 Miraglia R, Maruzzelli L, Di Piazza A. et al. Transjugular intrahepatic portosystemic shunt using the new gore Viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience. Cardiovasc Intervent Radiol 2019; 42 (01) 78-86
• 15 Gooch JW. Hagen-Poiseuille Equation. In: Gooch J.W.. (eds) Encyclopedic Dictionary of Polymers. New York, NY: Springer; 2011: 355 ; available at: https://doi.org/10.1007/978-1-4419-6247-8_5752
• 16 R Core Team. R: A Language and Environment for Statistical Computing. Published online 2021. Accessed February 13, 2024 at: https://www.R-project.org/